Our Capabilities

Comprehensive genomic solutions engineered for accuracy, speed, and stunning therapeutic impact.

Genomics

Genomic Sequencing

We sequence genomes with unparalleled accuracy. Our sequencing process relies heavily on next-gen platforms, deep-coverage, and meticulous bioinformatic detailing.

  • Sample Prep
  • Library Construction
  • High-Throughput Sequencing
  • Variant Calling
  • Annotation Pipelines
  • Quality Control
Microscope

AI Drug Discovery

Clean, efficient, and predictive modeling. We build algorithms that identify targets instantly and perform flawlessly across complex datasets.

  • Target Identification
  • Lead Optimization
  • TensorFlow / PyTorch
  • Molecular Docking
  • Toxicity Prediction
  • Binding Affinity
CRISPR

CRISPR Gene Editing

We build robust delivery mechanisms optimized for precision, enabling you to correct mutated alleles safely in-vivo.

  • Cas9/Cas12a Experts
  • Custom sgRNAs
  • LNP Delivery
  • Off-Target Analysis
  • AAV Vectors
  • Post-editing validation

Research FAQ

Everything you need to know about working with us.

A standard Phase I trial typically takes 12-18 months from approval to completion. Phase II and III trials can take 2-4 years depending on the complexity of the disease and patient cohorts required.

Yes! We offer comprehensive FDA and EMA filing packages. This ensures your therapies reach market legally, safely, and efficiently. We handle the regulatory burden so you can focus on the science.

We are platform-agnostic but primarily work with Illumina NovaSeq for whole genomes, PacBio for long-reads, and advanced Oxford Nanopore solutions for rapid clinical diagnostics.

Absolutely. We have dedicated patent attorneys who can create a cohesive IP strategy for you before we even start the in-vivo testing phase.
Ready to start? Partner with us